COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,878 Articles (22,568 medRxiv, 8,310 bioRxiv)

Most recent first Previous |  Page 915: Articles 9141-9150  | Next

Intracellular flow cytometry complements RT-qPCR detection of circulating SARS-CoV-2 variants of concern
Vanhulle, E., Provinciael, B., Stroobants, J., Camps, A., Maes, P., Vermeire, K.
10.1101/2022.02.02.478775 — Posted: 2022-02-02
Metabolic dyshomeostasis induced by SARS-CoV-2 structural proteins reveals immunological insights into viral olfactory interactions
Lachen-Montes, M., Mendizuri, N., Ausin, K., Echaide, M., Blanco, E., Chocarro, L., De Toro, M., Escors, D., Fernandez-Irigoyen, J., Kochan, G., Santamaria, E.
10.1101/2022.02.01.478724 — Posted: 2022-02-02
Chronic alcohol intake regulates expression of SARS-CoV2 infection-relevant genes in an organ-specific manner
Friske, M. M., Giannone, F., Senger, M., Seitz, R., Hansson, A. C., Spanagel, R.
10.1101/2022.02.01.478685 — Posted: 2022-02-02
Patterns of Volatility Across the Spike Protein Accurately Predict the Emergence of Mutations within SARS-CoV-2 Lineages
Rojas Chavez, R. A., Fili, M., Han, C., Rahman, S. A., Bicar, I. G. L., Hu, G., Das, J., Brown, G. D., Haim, H.
10.1101/2022.02.01.478697 — Posted: 2022-02-02
Design and development of potent h-ACE2 derived peptide mimetics in SARS-CoV-2 Omicron variant therapeutics
Paul, S. M. L., Nadendla, S., Sobhia, E. M.
10.1101/2022.02.01.478632 — Posted: 2022-02-02
USP22 controls type III interferon signaling and SARS-CoV-2 infection through activation of STING
Karlowitz, R., Stanifer, M. L., Roedig, J., Andrieux, G., Bojkova, D., Smith, S., Kowald, L., Schubert, R., Boerries, M., Cinatl, J., Boulant, S., van Wijk, S. J.
10.1101/2022.02.01.478628 — Posted: 2022-02-02
Why SARS-CoV-2 Omicron variant is milder? A single high-frequency mutation of structural envelope protein matters.
Xia, B., Wang, Y., Pan, X., Cheng, X., Ji, H., Zuo, X., Li, J., Gao, Z.
10.1101/2022.02.01.478647 — Posted: 2022-02-02
CLEC5A and TLR2 are critical in SARS-CoV-2-induced NET formation and lung inflammation
Sung, P.-S., Yang, S.-P., Peng, Y.-C., Sun, C.-P., Tao, M.-H., Hsieh, S.-L.
10.1101/2022.02.01.478701 — Posted: 2022-02-02
Hospitalisation for COVID-19 predicts long lasting cerebrovascular impairment: A prospective observational cohort study
Tsvetanov, K. A., Spindler, L. R. B., Stamatakis, E. A., Newcombe, V. F., Lupson, V. C., Chatfield, D. A., Manktelow, A. E., Outtrim, J. G., Elmer, A., Kingston, N., Bradley, J. R., Bullmore, E. T., Rowe, J. B., Menon, D. K., the Cambridge NeuroCOVID Group, , the NIHR COVID-19 BioResource, , the Cambridge NIHR Clinical Research Facility, , the CITIID-NIHR BioResource COVID-19 collaboration
10.1101/2022.02.01.22270235 — Posted: 2022-02-02
Understanding of and Trust in the Centers for Disease Control and Prevention's Revised COVID-19 Isolation and Quarantine Guidance Among US Adults
Mishra, V., Dexter, J. P.
10.1101/2022.02.01.22270288 — Posted: 2022-02-02 Discussion: Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).